Sonoma Pharmaceuticals Inc (SNOA)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $5.52M
Last updated: Nov 17, 2026 at 4:15 PM ET
Sonoma Pharmaceuticals Inc (SNOA) Stock Chart
Sonoma Pharmaceuticals (SNOA) has a latest price of $0.84 on Nov 17, 2026, 78.7% below its 52-week high of $3.95. Its price fell 75.6% over the past 12 months. The month-end price fell 99.8% over the 10 years through Oct 2026, a compound annual decline of 47.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $1,290.73 in Mar 2017 and its lowest $1.10 in Apr 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart SNOA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SNOA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 38.2%, and over 6 months it fell 16.8%. The month-end price fell 66.3% over the 3 years through Oct 2026, a compound annual decline of 30.4%.
| Period | Change |
|---|---|
| 1 month | -25.0% |
| 3 months | -38.2% |
| 6 months | -16.8% |
| 12 months | -75.6% |
| 12 months, with dividends | -75.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -66.3% | -30.4% |
| 5 years | -99.1% | -60.6% |
| 10 years | -99.8% | -47.7% |
Price by Year
Its best calendar year was 2020, when the price rose 66.5%, and its weakest was 2018, when it fell 86.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.10 | -69.8% |
| 2025 | $3.64 | +35.3% |
| 2024 | $2.69 | -25.4% |
| 2023 | $3.61 | -83.9% |
| 2022 | $22.40 | -75.4% |
| 2021 | $91.20 | -37.2% |
| 2020 | $145.20 | +66.5% |
| 2019 | $87.20 | -32.0% |
| 2018 | $128.26 | -86.9% |
| 2017 | $981.10 | +8.1% |
Trading Range
The price is 29.0% below its 50-day average of $1.18 and 46.5% below its 200-day average of $1.57.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.84 | |
| 52-week high | $3.95 | -78.7% |
| 52-week low | $0.80 | +5.0% |
| 50-day average | $1.18 | -29.0% |
| 200-day average | $1.57 | -46.5% |
Price Risk
Over 3 years, its largest fall from a peak was 90.2%.
| Measure | Value |
|---|---|
| 1-year beta | 1.43 |
| Largest fall, 1 year | -77.9% |
| Largest fall, 3 years | -90.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About SNOA
What is SNOA's 1-year price change?
Sonoma Pharmaceuticals's price fell 75.6% over the past 12 months. With dividends included, the 12-month total return was -75.6%.
What is SNOA's 5-year price change?
Sonoma Pharmaceuticals's month-end price fell 99.1% over the 5 years through Oct 2026, a compound annual decline of 60.6%. These figures leave out dividends.
What is SNOA's 52-week high and low?
Sonoma Pharmaceuticals's 52-week high is $3.95 and its 52-week low is $0.80. Its latest price of $0.84 on Nov 17, 2026 is 78.7% below the high.
What is SNOA's beta?
Sonoma Pharmaceuticals's 1-year beta against the S&P 500 is 1.43, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 77.9%.
Is the SNOA chart free?
Yes. Advanced Charting for SNOA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
SNOA pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors